207_Combined course Presentations

First page Table of contents Previous page 572 Next page Last page

C-RT + Pembrolizumab – a safety study

23 (85%) completed ≥ 200 mg cisplatin/m² 27 (100%) completed 70Gy of radiation

Powell ASCO 2017

Made with